| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$40 |
Application for quotation of securities - SEN
|
13 Jan 2025 9:26AM |
$0.027 |
$2.390 |
risen by
8,751.85%
|
|
| Pointerra Limited (3DP) ORDINARY FULLY PAID |
Information Technology |
$31 |
US$2 million Contract Extension from US Department of Energy
|
13 Jan 2025 9:25AM |
$0.049 |
$0.038 |
fallen by
22.45%
|
|
3DP - Price-sensitive ASX Announcement
Full Release
Key Points
- Pointerra awarded US$2 million contract extension by the US Department of Energy.
- Contract extension focuses on hurricane impact analysis to improve electric grid resilience.
- Pointerra will use 2D and 3D data for developing digital twins of affected utility grids.
- Results will provide best practices for resource allocation and outage reduction strategies.
- Program expected to be completed by 31 December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
Reinstatement to Quotation
|
13 Jan 2025 9:25AM |
$0.030 |
$0.465 |
risen by
1,450%
|
|
TNC - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension of trading in TNC securities lifted.
- Announcement concerning appointment of voluntary administrators.
- Compliance with ASX Listing Rules.
- Listing Rule 12.2 is specifically mentioned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
Paul Cronin appointed Non-Executive Chairman
|
13 Jan 2025 9:25AM |
$0.030 |
$0.465 |
risen by
1,450%
|
|
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
Change of Director's Interest Notice B Jones
|
13 Jan 2025 9:25AM |
$0.030 |
$0.465 |
risen by
1,450%
|
|
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
Shareholder Distribution Schedule
|
13 Jan 2025 9:25AM |
$0.030 |
$0.465 |
risen by
1,450%
|
|
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
Top 20 Shareholders
|
13 Jan 2025 9:25AM |
$0.030 |
$0.465 |
risen by
1,450%
|
|
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
Statement of Confirmations
|
13 Jan 2025 9:25AM |
$0.030 |
$0.465 |
risen by
1,450%
|
|
TNC - Price-sensitive ASX Announcement
Full Release
Key Points
- TNC will not ramp up production at processing facilities for the next 12 months.
- TNC intends to conduct exploration and evaluation activities during this period.
- The company complies with ASX Listing Rules and has confirmed the receipt of cleared funds from capital raising.
- TNC has provided a pro forma financial position statement based on recent capital raising.
- Funds raised will be allocated to debt repayment and exploration projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$220 |
Lumos Partners with MedPro for Sales of FebriDx in the US
|
13 Jan 2025 9:25AM |
$0.038 |
$0.280 |
risen by
636.84%
|
|
| Sandon Capital Investments Limited (SNC) ORDINARY FULLY PAID |
Financials |
$129 |
Net Tangible Assets as at 31 December 2024
|
13 Jan 2025 9:24AM |
$0.810 |
$0.885 |
risen by
9.26%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$731 |
Weekly Estimate NTA for 10.01.2025
|
13 Jan 2025 9:24AM |
$3.320 |
$3.470 |
risen by
4.52%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$72 |
Cynata to Present at Biotech Showcase
|
13 Jan 2025 9:24AM |
$0.230 |
$0.305 |
risen by
32.61%
|
|
| NRW Holdings Limited (NWH) ORDINARY FULLY PAID |
Industrials |
$2,366 |
Chief Financial Officer Resignation
|
13 Jan 2025 9:21AM |
$3.810 |
$5.150 |
risen by
35.17%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$35 |
Update - Notification of buy-back - MEC
|
13 Jan 2025 9:18AM |
$1.040 |
$1.110 |
risen by
6.73%
|
|
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$31 |
Summary of Pre-Feasibility Study for Nueva Sabana Mine
|
13 Jan 2025 9:17AM |
$0.003 |
$0.010 |
risen by
233.33%
|
|
AAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden Ore Reserve estimate of 1.76 million tonnes of probable ore.
- Average grade of 0.5% copper and 1.5 g/t gold.
- Projected mine life of approximately 4.6 years.
- Total net revenue estimated at USD 233.2 million.
- Total costs forecast to be USD 134.1 million.
- Projected net profit of USD 99.1 million.
- Environmental license secured for the project.
- Focus on employing local labor.
- Commitment to future agricultural initiatives post-mining.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vection Technologies Ltd (VR1) ORDINARY FULLY PAID |
Information Technology |
$70 |
EU XR Distribution and Nanotech Partnership
|
13 Jan 2025 9:17AM |
$0.039 |
$0.031 |
fallen by
20.51%
|
|
VR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Distribution deal with Synergy to expand into Bulgaria, targeting ~$600k in sales by 2027.
- Strengthened European market presence with active partnership negotiations in the Netherlands and Spain.
- Partnership with DigiLens, a nanotechnology leader, to integrate XR apps into ARGO smart glasses for industrial and government sectors.
- Enhanced cyber security and advanced spatial computing globally through DigiLens collaboration.
- Validation of Vection’s XR apps for deployment in the USA and other global markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Boulder Resources Limited (GBR) ORDINARY FULLY PAID |
Materials |
$91 |
Trading Halt
|
13 Jan 2025 9:17AM |
$0.047 |
$0.087 |
risen by
85.11%
|
|
GBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Great Boulder Resources Limited requested a trading halt.
- The halt is effective immediately.
- The reason for the halt is pending announcement of metallurgical test results.
- Normal trading is expected to resume on 15 January 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Salter Brothers Emerging Companies Limited (SB2) ORDINARY FULLY PAID |
Financials |
$61 |
Daily share buy-back notice
|
13 Jan 2025 9:15AM |
$0.820 |
$0.730 |
fallen by
10.98%
|
|
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$10 |
Change of Director's Interest Notice - P Thomas
|
13 Jan 2025 9:15AM |
$0.085 |
$0.055 |
fallen by
35.29%
|
|
| Renergen Limited (RLT) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$121 |
Announcement regarding share price volatility
|
13 Jan 2025 9:15AM |
$0.405 |
$0.815 |
risen by
101.23%
|
|
RLT - Price-sensitive ASX Announcement
Full Release
Key Points
- The Phase 1 plant is producing LNG from its wells and is selling this LNG to its customers.
- The Phase 1 plant is liquifying pure helium sourced from its wells.
- The cold box is at temperature and liquefying helium as it should.
- The efficiency will be improved through the additional drilling of wells.
- Our liquid helium achieves purity of a minimum of 99.999%.
- Shareholders are advised that the Company has not entered any business rescue discussions.
- Renergen cautions shareholders against making investment decisions based on speculation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FBR Ltd (FBR) ORDINARY FULLY PAID |
Industrials |
$27 |
FBR receives A$6.3 million R&D Tax Incentive Cash Rebate
|
13 Jan 2025 9:15AM |
$0.038 |
$0.004 |
fallen by
89.47%
|
|
FBR - Price-sensitive ASX Announcement
Full Release
Key Points
- FBR Limited received A$6.3 million R&D tax incentive cash rebate.
- The rebate is for the year ended 30 June 2024.
- A$4.3 million drawn from R&D revolving tax loan facility will be repaid.
- A$2 million cash will be retained by FBR after repayment.
- FBR received final tranche of US$400,000 from CRH Ventures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$372 |
NAV 31 December 2024
|
13 Jan 2025 9:14AM |
$1.310 |
$1.390 |
risen by
6.11%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$178 |
ACW presents at Sachs Neuro & WHO grants INN emestedastat
|
13 Jan 2025 9:14AM |
$0.025 |
$0.056 |
risen by
124%
|
|
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$11,063 |
LIT: Next steps agreed for LieNA commercialisation pathway
|
13 Jan 2025 9:14AM |
$34.400 |
$55.980 |
risen by
62.73%
|
|
MIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Livium and MinRes agree on Stage 1A activities for LieNA technology.
- Activities focus on optimising the commercialisation pathway for lithium production.
- Funding for Stage 1A comes from convertible note and R&D tax incentives.
- Maturity date for convertible note extended to September 2025.
- Completion of Stage 1A may lead to a joint venture between Livium and MinRes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$21 |
Next steps agreed for LieNA commercialisation pathway
|
13 Jan 2025 9:14AM |
$0.016 |
$0.010 |
fallen by
37.50%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Livium and MinRes agree additional Stage 1A Activities under the JDA to optimise the commercialisation pathway for the LieNA® technology.
- The additional Stage 1A activities will be fully funded via the remaining balance of the Convertible Note Deed and LieNA® R&D tax incentive rebates.
- To allow the Stage 1A Activities to complete, the maturity date of the Convertible Note Deed has been extended to 30 September 2025.
- Satisfactory completion of Stage 1 Activities marks a significant milestone for LieNA®.
- Funding allows the Stage 1A Activities to advance without any dilutionary impacts for shareholders.
- Livium continues to progress its collaboration with MinRes to evaluate the preferred commercialisation pathway for the Company’s LieNA® technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.